Optimization manufacture of virus- and tumor-specific T cells

Stem Cells International

Volumn , Issue , 2011, Pages

  Lapteva, Natalia ^a   Vera, Juan F ^a  

^a CENTER FOR CELL AND GENE THERAPY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC ANTIGEN RECEPTOR; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ADENOVIRUS; ALLOIMMUNITY; ANTIGEN SPECIFICITY; BIOPROCESS; BIOREACTOR; CELL DAMAGE; CELL DENSITY; CELL EXPANSION; CELL GROWTH; CELL MANIPULATION; CELL STIMULATION; CELL SURVIVAL; CELL THERAPY; CELL VIABILITY; CLINICAL PROTOCOL; CULTURE OPTIMIZATION; CULTURE VESSEL; CYTOMEGALOVIRUS; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; EX VIVO CELL EXPANSION; EXPERIMENTAL THERAPY; GOOD MANUFACTURING PRACTICE; HUMAN; LYMPHOCYTE CULTURE; LYMPHOCYTE TRANSFER; LYMPHOMA; MELANOMA; NASOPHARYNX CARCINOMA; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 81555203155     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.4061/2011/434392     Document Type: Review

References (35)

1. Leen A. M., Christin A., Myers G. D., Liu H., Cruz C. R., Hanley P. J., Kennedy-Nasser A. A., Leung K. S., Gee A. P., Krance R. A., Brenner M. K., Heslop H. E., Rooney C. M., Bollard C. M., Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation Blood 2009 114 19 4283 4292
2. Cobbold M., Khan N., Pourgheysari B., Tauro S., McDonald D., Osman H., Assenmacher M., Billingham L., Steward C., Crawley C., Olavarria E., Goldman J., Chakraverty R., Mahendra P., Craddock C., Moss P. A. H., Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers Journal of Experimental Medicine 2005 202 3 379 386 (Pubitemid 41126955)
3. Einsele H., Roosnek E., Rufer N., Sinzger C., Riegler S., Loffler J., Grigoleit U., Moris A., Rammensee H. G., Kanz L., Kleihauer A., Frank F., Jahn G., Hebart H., Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy Blood 2002 99 11 3916 3922 (Pubitemid 35332029)
4. Rooney C. M., Smith C. A., Ng C. Y., Loftin S. K., Sixbey J. W., Gan Y., Srivastava D. K., Bowman L. C., Krance R. A., Brenner M. K., Heslop H. E., Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients Blood 1998 92 5 1549 1555 (Pubitemid 28406858)
5. Bollard C. M., Gottschalk S., Leen A. M., Weiss H., Straathof K. C., Carrum G., Khalil M., Wu M. F., Huls M. H., Chang C. C., Gresik M. V., Gee A. P., Brenner M. K., Rooney C. M., Heslop H. E., Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer Blood 2007 110 8 2838 2845 (Pubitemid 350006936)
6. Porter D. L., Levine B. L., Bunin N., Stadtmauer E. A., Luger S. M., Goldstein S., Loren A., Phillips J., Nasta S., Perl A., Schuster S., Tsai D., Sohal A., Veloso E., Emerson S., June C. H., A phase 1 trial of donor lymphocyte infusions expanded and activated ex vivo via CD3/CD28 costimulation Blood 2006 107 4 1325 1331 (Pubitemid 43242365)
7. Hong J. J., Rosenberg S. A., Dudley M. E., Yang J. C., White D. E., Butman J. A., Sherry R. M., Successful treatment of melanoma brain metastases with adoptive cell therapy Clinical Cancer Research 2010 16 19 4892 4898
8. Morgan R. A., Dudley M. E., Wunderlich J. R., Hughes M. S., Yang J. C., Sherry R. M., Royal R. E., Topalan S. L., Kammula U. S., Restifo N. P., Zheng Z., Nahvi A., De Vries C. R., Rogers-Freezer L. J., Mavroukakis S. A., Rosenberg S. A., Cancer regression in patients after transfer of genetically engineered lymphocytes Science 2006 314 5796 126 129 (Pubitemid 44547756)
9. Comoli P., Pedrazzoli P., Maccario R., Basso S., Carminati O., Labirio M., Schiavo R., Secondino S., Frasson C., Perotti C., Moroni M., Locatelli F., Siena S., Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytes Journal of Clinical Oncology 2005 23 35 8942 8949 (Pubitemid 46211479)
10. Louis C. U., Straathof K., Bollard C. M., Ennamuri S., Gerken C., Lopez T. T., Huls M. H., Sheehan A., Wu M. F., Liu H., Gee A., Brenner M. K., Rooney C. M., Heslop H. E., Gottschalk S., Adoptive transfer of EBV-specific T cells results in sustained clinical responses in patients with locoregional nasopharyngeal carcinoma Journal of Immunotherapy 2010 33 9 983 990
11. Pule M. A., Savoldo B., Myers G. D., Rossig C., Russell H. V., Dotti G., Huls M. H., Liu E., Gee A. P., Mei Z., Yvon E., Weiss H. L., Liu H., Rooney C. M., Heslop H. E., Brenner M. K., Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma Nature Medicine 2008 14 11 1264 1270
12. Tiberghien P., Ferrand C., Lioure B., Milpied N., Angonin R., Deconinck E., Certoux J. M., Robinet E., Saas P., Petracca B., Juttner C., Reynolds C. W., Longo D. L., Hervé P., Cahn J. Y., Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft Blood 2001 97 1 63 72 (Pubitemid 32061243)
13. Yvon E., Del V. M., Savoldo B., Hoyos V., Dutour A., Anichini A., Dotti G., Brenner M. K., Immunotherapy of metastatic melanoma using genetically engineered GD2-specific T cells Clinical Cancer Research 2009 15 18 5852 5860
14. Eshhar Z., Waks T., Gross G., Schindler D. G., Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors Proceedings of the National Academy of Sciences of the United States of America 1993 90 2 720 724 (Pubitemid 23028937)
15. Di S. A., De A. B., Rooney C. M., Zhang L., Mahendravada A., Foster A. E., Heslop H. E., Brenner M. K., Dotti G., Savoldo B., T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model Blood 2009 113 25 6392 6402
16. Dilloo D., Bacon K., Holden W., Zhong W., Burdach S., Zlotnik A., Brenner M., Combined chemokine and cytokine gene transfer enhances antitumor immunity Nature Medicine 1996 2 10 1090 1095 (Pubitemid 26338627)
17. Ciceri F., Bonini C., Stanghellini M. T., Bondanza A., Traversari C., Salomoni M., Turchetto L., Colombi S., Bernardi M., Peccatori J., Pescarollo A., Servida P., Magnani Z., Perna S. K., Valtolina V., Crippa F., Callegaro L., Spoldi E., Crocchiolo R., Fleischhauer K., Ponzoni M., Vago L., Rossini S., Santoro A., Todisco E., Apperley J., Olavarria E., Slavin S., Weissinger E. M., Ganser A., Stadler M., Yannaki E., Fassas A., Anagnostopoulos A., Bregni M., Stampino C. G., Bruzzi P., Bordignon C., Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study The Lancet Oncology 2009 10 5 489 500
18. Thomis D. C., Marktel S., Bonini C., Traversari C., Gilman M., Bordignon C., Clackson T., A Fas-based suicide switch in human T cells for the treatment of graft-versus-host disease Blood 2001 97 5 1249 1257 (Pubitemid 32183746)
19. Straathof K. C., Pule M. A., Yotnda P., Dotti G., Vanin E. F., Brenner M. K., Heslop H. E., Spencer D. M., Rooney C. M., An inducible caspase 9 safety switch for T-cell therapy Blood 2005 105 11 4247 4254 (Pubitemid 40720769)
20. Tey S. K., Dotti G., Rooney C. M., Heslop H. E., Brenner M. K., Inducible caspase 9 suicide gene to improve the safety of allodepleted T cells after haploidentical stem cell transplantation Biology of Blood and Marrow Transplantation 2007 13 8 913 924 (Pubitemid 47055386)
21. Yee C., Thompson J. A., Byrd D., Riddell S. R., Roche P., Celis E., Greenberg P. D., Adoptive T cell therapy using antigen-specific CD8 + T cell clones for the treatment of patients with metastatic melanoma: In vivo persistence, migration, and antitumor effect of transferred T cells Proceedings of the National Academy of Sciences of the United States of America 2002 99 25 16168 16173 (Pubitemid 35462767)
22. Schultze J. L., Michalak S., Seamon M. J., Dranoff G., Jung K., Daley J., Delgado J. C., Gribben J. G., Nadler L. M., CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy Journal of Clinical Investigation 1997 100 11 2757 2765 (Pubitemid 28007544)
23. Malone C. C., Schiltz P. M., Mackintosh A. D., Beutel L. D., Heinemann F. S., Dillman R. O., Characterization of human tumor-infiltrating lymphocytes expanded in hollow-fiber bioreactors for immunotherapy of cancer Cancer Biotherapy and Radiopharmaceuticals 2001 16 5 381 390 (Pubitemid 33151115)
24. Leong M., Babbitt W., Vyas G., A hollow-fiber bioreactor for expanding HIV-1 in human lymphocytes used in preparing an inactivated vaccine candidate Biologicals 2007 35 4 227 233 (Pubitemid 47566449)
25. Tran C. A., Burton L., Russom D., Wagner J. R., Jensen M. C., Forman S. J., DiGiusto D. L., Manufacturing of large numbers of patient-specific T cells for adoptive immunotherapy: an approach to improving product safety, composition, and production capacity Journal of Immunotherapy 2007 30 6 644 654 (Pubitemid 47229699)
26. Bohnenkamp H., Hilbert U., Noll T., Bioprocess development for the cultivation of human T-lymphocytes in a clinical scale Cytotechnology 2002 38 1-3 135 145 (Pubitemid 35307416)
27. Lamers C. H., Gratama J. W., Luider-Vrieling B., Bolhuis R. L., Bast E. J., Large-scale production of natural cytokines during activation and expansion of human T lymphocytes in hollow fiber bioreactor cultures Journal of Immunotherapy 1999 22 4 299 307 (Pubitemid 29309962)
28. Carswell K. S., Papoutsakis E. T., Culture of human T cells in stirred bioreactors for cellular immunotherapy applications: shear, proliferation, and the IL-2 receptor Biotechnology and Bioengineering 2000 68 3 328 338 (Pubitemid 30230403)
29. Thompson J. A., Figlin R. A., Sifri-Steele C., Berenson R. J., Frohlich M. W., A phase I trial of CD3/CD28-activated T Cells (Xcellerated T Cells) and interleukin-2 in patients with metastatic renal cell carcinoma Clinical Cancer Research 2003 9 10 3562 3570 (Pubitemid 37169219)
30. Levine B. L., T lymphocyte engineering ex vivo for cancer and infectious disease Expert Opinion on Biological Therapy 2008 8 4 475 489 (Pubitemid 351570411)
31. Rapoport A. P., Aqui N. A., Stadtmauer E. A., Vogl D. T., Fang H. -B., Cai L., Janofsky S., Chew A., Storek J., Akpek G., Badros A., Yanovich S., Tan M. T., Veloso E., Pasetti M. F., Cross A., Philip S., Murphy H., Bhagat R., Zheng Z., Milliron T., Cotte J., Cannon A., Levine B. L., Vonderheide R. H., June C. H., Combination immunotherapy using adoptive T-cell transfer and tumor antigen vaccination on the basis of hTERT and survivin after ASCT for myeloma Blood 2011 117 3 788 797
32. Vera J. F., Brenner L. J., Gerdemann U., Ngo M. C., Sili U., Liu H., Wilson J., Dotti G., Heslop H. E., Leen A. M., Rooney C. M., Accelerated production of antigen-specific T cells for preclinical and clinical applications using gas-permeable rapid expansion cultureware (G-Rex) Journal of Immunotherapy 2010 33 3 305 315
33. Haque T., Wilkie G. M., Jones M. M., Higgins C. D., Urquhart G., Wingate P., Burns D., McAulay K., Turner M., Bellamy C., Amlot P. L., Kelly D., MacGilchrist A., Gandhi M. K., Swerdlow A. J., Crawford D. H., Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial Blood 2007 110 4 1123 1131 (Pubitemid 47281407)
34. Barker J. N., Doubrovina E., Sauter C., Jaroscak J. J., Perales M. A., Doubrovin M., Prockop S. E., Koehne G., O'Reilly R. J., Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes Blood 2010 116 23 5045 5049
35. Gerdemann U., Christin A. S., Vera J. F., Ramos C. A., Fujita Y., Liu H., Dilloo D., Heslop H. E., Brenner M. K., Rooney C. M., Leen A. M., Nucleofection of DCs to generate multivirus-specific T cells for prevention or treatment of viral infections in the immunocompromised host Molecular Therapy 2009 17 9 1616 1625